Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Phase: Phase 3"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Coronavirus+Infections%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Coronavirus+Infections%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Coronavirus+Infections%22&type=Subject
PubPharm (58)
1
A phase I/III study to assess pre-exposure prophylaxis of AZD5156 in immunocompromised individuals : A Phase I/III Randomized, Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment - SUPERNOVA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A phase I/III study to assess pre-exposure prophylaxis of AZD5156 in immunocompromised individuals : A Phase I/III Randomized, Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment - SUPERNOVA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Therapeutics for Inpatients with COVID-19 (TICO) : A Multicentre, Adaptive, Randomised, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsfor Hospitalised Patients with COVID-19Short Title: Therapeutics for Inpatients with COVID-19 (TICO)INSIGHT Protocol Number: 014 / ACTIV-3 - Therapeutics for Inpatients with COVID-19 (TICO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Therapeutics for Inpatients with COVID-19 (TICO) : A Multicentre, Adaptive, Randomised, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsfor Hospitalised Patients with COVID-19Short Title: Therapeutics for Inpatients with COVID-19 (TICO)INSIGHT Protocol Number: 014 / ACTIV-3 - Therapeutics for Inpatients with COVID-19 (TICO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19 : A randomised, double-blind, placebo-controlled, Phase III trial to determine the efficacy and safety of inhaled SNG001 for the treatment of patients hospitalised due to moderate COVID-19 - SPRINTER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19 : A randomised, double-blind, placebo-controlled, Phase III trial to determine the efficacy and safety of inhaled SNG001 for the treatment of patients hospitalised due to moderate COVID-19 - SPRINTER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19 - Phase 3 Double-blind study of AZD7442 or Placebo for Pre-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection : A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Pre-exposure Prophylaxis of COVID-19 - Phase 3 Double-blind study of AZD7442 or Placebo for Pre-exposure Prophylaxis of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A Study to Evaluate Additional Dose(s) of BNT162b2 in Healthy Individuals Previously Vaccinated With BNT162b2 : A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF BNT162b2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162b2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
A Study to Evaluate Additional Dose(s) of BNT162b2 in Healthy Individuals Previously Vaccinated With BNT162b2 : A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF BNT162b2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162b2
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 3
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Medienart
58
Aufsätze
58
E-Artikel
58
E-Ressourcen
Zeitschriftentitel
58
WHO International Clinical Trials Registry Plat...
Thema
58
610
Phase: Phase 3
Recruitment Status: Authorised-recruitment may ...
58
Study Type: Interventional
10
Medical Condition: COVID-19 MedDRA version: 23....
6
Medical Condition: COVID-19 (Coronavirus Diseas...
6
Medical Condition: COVID-19 MedDRA version: 23....
6
Medical Condition: COVID-19 infection MedDRA ve...
4
Medical Condition: Severe Acute Respiratory Syn...
2
Medical Condition: COVID-19 (Coronavirus RNA) M...
2
Medical Condition: COVID-19 (SARS-CoV-2) infect...
2
Medical Condition: COVID-19 Infection MedDRA ve...
2
Medical Condition: COVID-19 MedDRA version: 23....
2
Medical Condition: Coronavirus disease 2019 (CO...
2
Medical Condition: Coronavirus disease 2019 (CO...
2
Medical Condition: Cov-2 SARS Disease MedDRA ve...
2
Medical Condition: Covid-19 coronavirus infecti...
2
Medical Condition: Infection with Severe Acute ...
2
Medical Condition: Patients = 18 years old with...
2
Medical Condition: Protection against COVID-19 ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
8
2022
22
2021
26
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
58
Englisch
Haven't found what you're looking for?
Wird geladen...